Does insurance cover bioidentical hormones? In almost every case, yes for FDA-approved bioidentical products like estradiol patches and micronized progesterone capsules, and no for compounded bioidentical hormone therapy mixed by a pharmacy. The word “bioidentical” sits on both categories in marketing, but insurers treat them as entirely different products.
FDA-Approved Bioidentical Hormones Your Plan Likely Covers
FDA-approved bioidentical hormones have gone through clinical trials, carry standardized labeling, and are manufactured under federal quality controls.1Endocrine Society. Compounded Bioidentical Hormone Therapy Commercial plans, Medicare Part D, and Medicaid treat them as ordinary prescription drugs.
The commonly prescribed products, by delivery method, include:2GoodRx. Bioidentical Hormone Therapy
- Patches: Climara, Vivelle-Dot, Alora, Dotti (all estradiol)
- Gels and sprays: Divigel, EstroGel, Elestrin, Evamist (estradiol)
- Oral capsules: Prometrium (micronized progesterone), Bijuva (estradiol and progesterone combination)
- Vaginal products: Estrace cream, Femring, Estring, Imvexxy, Intrarosa (DHEA for vaginal symptoms)
- Injectable: Depo-Estradiol
More than 90 percent of Medicare and Medicaid plans cover estradiol, the most widely prescribed form of hormone replacement therapy.3GoodRx. HRT Cost Generic estradiol patches run roughly $12 with insurance at some pharmacies, versus a retail price around $74 without coverage.4Amazon Pharmacy. Estradiol Generic for Climara Transdermal System Coverage is not uniform across the formulary, though. Many approved bioidentical products sit on higher tiers with higher copays. Bijuva, the only FDA-approved estradiol-progesterone combination capsule, is non-formulary in the VA system and requires prior approval.5VA Formulary Advisor. Estradiol/Progesterone Cap Oral
One gap matters here: no FDA-approved testosterone product is specifically indicated for menopausal symptoms in women.6ACOG. Compounded Bioidentical Menopausal Hormone Therapy That is one reason testosterone coverage for women is especially hard to secure.
Why Compounded Bioidentical Hormones Get Denied
Compounded bioidentical hormones are custom formulations prepared by a compounding pharmacy. They have not been reviewed by the FDA for safety, efficacy, or manufacturing quality.7Cleveland Clinic. Bioidentical Hormones Every major commercial insurer in the United States classifies them as experimental or investigational:
- Aetna calls bioidentical hormones “experimental, investigational, or unproven,” citing an FDA analysis in which 34 percent of samples from compounding pharmacies failed standard quality tests.8Aetna. Bioidentical Hormones
- UnitedHealthcare states that compounded hormone products, including compounded testosterone, estrogen, and progesterone pellets, are “not proven or medically necessary for any indication.”9UnitedHealthcare. Testosterone Replacement Supplementation Therapy
- Cigna labels compounded hormone pellets experimental and investigational, and requires patients to have tried and failed up to five FDA-approved alternatives before any compounded medication can be considered medically necessary.10Cigna. Coverage Position Criteria – Compounded Medications
- Blue Cross Blue Shield of Mississippi considers subcutaneous hormone pellet implantation, including bioidentical formulations, investigational and not medically necessary for women.11BCBS Mississippi. Hormone Pellet Implantation for Hormone Replacement Therapy in Women
- Medica classifies compounded bioidentical hormone replacement products and associated services as “investigative” and not covered, effective May 1, 2026.12Medica. Bioidentical Hormone Replacement Therapy Coverage Policy
The clinical establishment backs those policies. The American College of Obstetricians and Gynecologists advises against routine prescription of compounded bioidentical menopausal hormone therapy when FDA-approved formulations exist, pointing to inconsistent potency and contamination risk.6ACOG. Compounded Bioidentical Menopausal Hormone Therapy A 2020 National Academies report concluded that widespread use of compounded bioidentical hormones “poses a public health concern.”13FDA. NASEM Study – Clinical Utility of Treating Patients
The Testopel Exception for Pellets
Testopel, an FDA-approved subcutaneous testosterone pellet, is the one pellet-based hormone therapy insurers sometimes cover. Aetna considers it medically necessary for delayed male puberty, confirmed hypogonadism, and gender dysphoria, but not for age-related low testosterone, menopausal symptoms, or pain management in women.14Aetna. Implantable Hormone Pellets UnitedHealthcare covers it under similar conditions, requiring two confirmed low morning testosterone levels below 300 ng/dL for hypogonadism patients.15UnitedHealthcare. Testosterone Replacement Supplementation Therapy – Community Plan Blue Cross Blue Shield federal plans cover Testopel with prior authorization and a quantity limit of six pellets per 90 days.16FEP Blue. Testosterone Implant Injectable
Pellets containing estrogen, progesterone, or non-FDA-approved testosterone formulations stay excluded. Aetna classifies estradiol pellets as experimental because no FDA-approved commercial formulation exists and because they produce unpredictable serum concentrations.14Aetna. Implantable Hormone Pellets
Medicare and Medicaid
Original Medicare (Parts A and B) does not cover outpatient prescription hormones. Medicare Part D and Medicare Advantage plans with drug benefits may cover FDA-approved bioidentical hormones such as estradiol and progesterone, with coverage depending on each plan’s formulary.17Medigap.com. Hormone Replacement Therapy Medicare Coverage Providers must document medical necessity, and beneficiaries still owe their deductible, coinsurance, or copay.
Compounded bioidentical hormones are rarely covered by Medicare.17Medigap.com. Hormone Replacement Therapy Medicare Coverage Expect to pay the full price if you choose a compounded prescription under a Medicare plan.
What You Pay Without Coverage
Out of pocket, compounded bioidentical hormones typically run $60 to $250 per month, depending on delivery method and the complexity of the formula.18MediVera Rx. Does Insurance Cover Bioidentical Hormone Replacement Therapy Factoring in lab work, consultations, and follow-up visits, some estimates put the total at $200 to $500 per month.19Berman Sexual Health. Average Monthly Cost Bioidentical Hormones Pellet therapy, billed every three to six months, works out to roughly $100 to $125 per month for women and $67 to $267 per month for men.20Med Spa of DFW. Hormone Replacement Therapy Cost
FDA-approved alternatives are often cheaper even at cash prices. Generic estradiol tablets can cost as little as $13 per month at retail, and estradiol patches about $60 per month.21Asheville Compounding Pharmacy. Cost of Bioidentical Hormone Replacement Therapy
If Your Claim Is Denied
Prior Authorization and Appeals
Even FDA-approved bioidentical hormones sometimes require prior authorization. When a pharmacy flags one, the request usually goes from the pharmacy to your provider. Insurers can take up to 14 business days to respond.22FOLX Health. Prior Authorizations – What to Know Once approved, call the pharmacy and ask them to re-run the prescription through insurance.
If a claim is denied, your insurer must send a denial letter explaining why and how to appeal. Appeals typically take 7 to 30 days. If the first appeal fails, your provider can request a peer-to-peer review, a direct conversation between your doctor and the insurer’s medical reviewer.22FOLX Health. Prior Authorizations – What to Know Keep a log of every call: date, time, and the representative’s name.23Point of Pride. Do I Need a Prior Authorization to Start HRT
Step Therapy
Some plans require step therapy, also called “fail-first.” You must try a less expensive or preferred medication first, and a trial period generally has to run at least six months of consistent use before the insurer counts it as a failure.23Point of Pride. Do I Need a Prior Authorization to Start HRT You can call your insurer at any time to ask whether step therapy applies to your prescription and which alternatives qualify.24Planned Parenthood Michigan. Prior Authorizations
HSA and FSA Accounts
Hormone replacement therapy, including compounded formulations, is eligible for reimbursement through a Health Savings Account, Flexible Spending Account, or Health Reimbursement Arrangement as long as a licensed provider has written the prescription.25FSA Store. Hormone Replacement Therapy These accounts follow IRS rules rather than insurer coverage decisions, so a treatment denied by your plan can still be paid with pre-tax dollars.26Defiance Health. Can You Use HSA or FSA at Defiance Health Lab work, consultations, and follow-ups also qualify. If your administrator asks for proof, your provider can supply a letter of medical necessity.
State Laws That May Change the Answer
Several states have passed or proposed menopause coverage mandates that affect FDA-approved bioidentical options.
Louisiana’s House Bill 392 took effect August 1, 2024. It requires Medicaid and private health plans to cover menopause and perimenopause treatment, including hormone replacement therapy, and prohibits prior authorization, step therapy, or fail-first requirements for those prescriptions.27Oklahoma Voice. Louisiana Mandates Insurance Coverage for Menopause, Perimenopause Treatment28Louisiana State Legislature. RS 22:988 – Perimenopausal and Menopausal Care
Illinois has required coverage for medically necessary hormone therapy to treat menopause induced by hysterectomy since January 1, 2024. Beginning January 1, 2026, an expanded version requires coverage for all medically necessary hormonal and non-hormonal menopause therapies, including FDA-approved oral, transdermal, topical, and vaginal ring formulations.29Illinois General Assembly. 215 ILCS 5/356z.56 – Coverage for Hormonal and Non-Hormonal Therapy to Treat Menopause
California Assembly Bill 432 would have required insurance plans to cover perimenopause and menopause evaluation and treatment, including at least one option in each FDA-approved systemic hormone therapy formulation. It passed the legislature but was vetoed by the governor.30LegiScan. AB432 – Menopause A February 2026 budget proposal in California would expand prescription drug coverage for perimenopause and menopause and mandate insurance-covered screenings for women over 40.31CapRadio. Insurance Is Often a Barrier to Menopause Symptom Treatment
Nevada mandates insurance coverage for hormone replacement therapy “in certain circumstances” under the state’s essential health benefits framework.32SelectHealth. Nevada EHB None of the current state mandates require coverage for compounded formulations.